Lennox-Gastaut Syndrome

UCB takes on Jazz in severe epilepsy with new Fintepla approval
Pharmaforum
Mon, 03/28/22 - 10:06 am
UCB Pharma
FDA
Fintepla
Lennox-Gastaut Syndrome
Jazz Pharma
Epidiolex
Ovid gets quick raise off PhII seizure results. Can the results hold up against GW?
Endpoints
Tue, 08/25/20 - 09:57 pm
Ovid Therapeutics
clinical trials
Takeda
Dravet syndrome
Lennox-Gastaut Syndrome
GW Pharma
Zogenix's Positive Clinical Trial Wasn't Positive Enough
Motley Fool
Sun, 02/9/20 - 04:08 pm
Zogenix
epilepsy
Lennox-Gastaut Syndrome
clinical trials
Fintepla
GW Pharma
Epidiolex
Zogenix hands GW a win
EP Vantage
Fri, 02/7/20 - 10:32 am
Lennox-Gastaut Syndrome
clinical trials
Fintepla
Zogenix
GW Pharma
Upcoming events – Genmab's route to market, and late-stage data for Zogenix
EP Vantage
Fri, 01/24/20 - 10:50 am
Genmab
tisotumab vedotin
cervical cancer
Zogenix
Fintepla
Lennox-Gastaut Syndrome
GW announces US launch of cannabinoid medicine for seizures
Pharmaceutical Business Review
Fri, 11/2/18 - 11:25 am
GW Pharma
Greenwich. Epidiolex
drug launches
Dravet syndrome
Lennox-Gastaut Syndrome
FDA approves country’s first medicine made from marijuana
Stat
Mon, 06/25/18 - 12:51 pm
GW Pharma
Epidiolex
epilepsy
FDA
Dravet syndrome
Lennox-Gastaut Syndrome
marijuana
This Cannabis-Based Drug Is On the Verge of Making History
Motley Fool
Sun, 05/20/18 - 08:40 pm
GW Pharma
Epidiolex
CBD
Dravet syndrome
Lennox-Gastaut Syndrome
FDA
Lundbeck Reports Positive Phase III Study Results for Clobazam in the Adjunctive Treatment of Seizures Associated with Lennox-Gastaut Syndrome
BusinessWire
Sun, 12/5/10 - 12:11 pm
Lennox-Gastaut Syndrome
epilepsy
clobazam
Lundbeck